After Touching 52-Week High, Is IntriCon Corporation (IIN)’s Near-Term Analysis Positive?

September 17, 2017 - By Adrian Mccoy

Investors sentiment decreased to 0.88 in 2016 Q4. Its down 0.55, from 1.43 in 2016Q3. It is negative, as 2 investors sold IntriCon Corporation shares while 6 reduced holdings. 2 funds opened positions while 5 raised stakes. 1.72 million shares or 6.20% more from 1.62 million shares in 2016Q3 were reported.
1 were reported by Wells Fargo & Mn. Northern stated it has 15,645 shares. Bank Of America Corp De owns 0% invested in IntriCon Corporation (NASDAQ:IIN) for 1,000 shares. California Pub Employees Retirement Sys stated it has 34,116 shares. Blackrock Fund Advsrs, California-based fund reported 15,796 shares. Morgan Stanley accumulated 38,000 shares or 0% of the stock. Blackrock Mgmt owns 1,076 shares. Vanguard Gru Incorporated holds 0% of its portfolio in IntriCon Corporation (NASDAQ:IIN) for 19,478 shares. Moreover, Blackrock Institutional Tru Na has 0% invested in IntriCon Corporation (NASDAQ:IIN) for 10,044 shares. 1492 Capital Management Limited Liability Company owns 54,353 shares or 0.29% of their US portfolio. Tower Research Capital Llc (Trc) has invested 0% in IntriCon Corporation (NASDAQ:IIN). Blackrock Advsrs Limited Liability Co invested 0% of its portfolio in IntriCon Corporation (NASDAQ:IIN). Moreover, Renaissance Techs Ltd Liability has 0% invested in IntriCon Corporation (NASDAQ:IIN). Bridgeway Capital Mgmt reported 21,500 shares. Heartland Advsrs Inc accumulated 550,000 shares or 0.21% of the stock.

The stock of IntriCon Corporation (NASDAQ:IIN) hit a new 52-week high and has $11.80 target or 4.00 % above today’s $11.35 share price. The 6 months bullish chart indicates low risk for the $77.75 million company. The 1-year high was reported on Sep, 17 by If the $11.80 price target is reached, the company will be worth $3.11 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.44% or $0.05 on September 15, reaching $11.35. About 125,344 shares traded or 260.98% up from the average. IntriCon Corporation (NASDAQ:IIN) has risen 44.30% since September 17, 2016 and is uptrending. It has outperformed by 27.60% the S&P500.

Analysts expect IntriCon Corporation (NASDAQ:IIN) to report $0.09 EPS on November, 13.They anticipate $0.28 EPS change or 147.37 % from last quarter’s $-0.19 EPS. IIN’s profit would be $616,520 giving it 31.53 P/E if the $0.09 EPS is correct. After having $0.08 EPS previously, IntriCon Corporation’s analysts see 12.50 % EPS growth.

IntriCon Corporation (NASDAQ:IIN) Ratings Coverage

Among 3 analysts covering IntriCon (NASDAQ:IIN), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. IntriCon had 3 analyst reports since September 22, 2015 according to SRatingsIntel. The company was maintained on Friday, February 17 by Dougherty & Company. Longbow downgraded the shares of IIN in report on Friday, August 25 to “Neutral” rating. The rating was downgraded by Zacks on Tuesday, September 22 to “Sell”.

More notable recent IntriCon Corporation (NASDAQ:IIN) news were published by: which released: “11.35” on April 23, 2011, also with their article: “IntriCon Names Jim Houlihan Vice President of Direct-to-Consumer Hearing …” published on July 31, 2017, published: “IntriCon Corp. acquires London-based PC Werth” on November 03, 2015. More interesting news about IntriCon Corporation (NASDAQ:IIN) were released by: and their article: “IntriCon Exercises Option to Acquire Remaining Stake in Hearing Help Express” published on January 19, 2017 as well as‘s news article titled: “IntriCon Corporation’s (IIN) CEO Mark Gorder on Q2 2017 Results – Earnings …” with publication date: August 02, 2017.

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The company has market cap of $77.75 million. The Firm operates through body-worn device segment. It currently has negative earnings. The Firm serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: